Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

ATAI Life Sciences

Request full access

A biotechnology company pioneering mental health innovation

Berlin, GermanyFounded 2018Biotech & Life Sciences

At a glance

Status
Listed
Listing
IPO 2021

ATAI Life Sciences in the Berlin ecosystem

Live from Dealroom

The ATAI Life Sciences office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

21 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

  • Apeiron Investment Group
  • HCS

Series A3 investors entered at this stage

Series B and later16 investors entered at this stage

  • What If Ventures
  • Fearless Ventures
  • Woodline Partners
  • Maryanna Saenko
  • Efrem Kamen
  • Highline Capital Management
  • Catalio Capital Management
  • Alpha Wave Global
  • Pura Vida Investments
  • Thiel Capital
  • Steve Jurvetson
  • Future Ventures
  • Neo Kuma Ventures
  • Christian Angermayer
  • Subversive Capital
  • Galaxy Investment Partners (Galaxy Digital)
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia 4 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇩🇪 Germany · Berlin HQ
Book a demo for the full country breakdown

Patents

Estimated portfolio value
$12M

77 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where ATAI Life Sciences was the backer or acquirer, 2020–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

9 deals across ATAI Life Sciences's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        Where ATAI Life Sciences deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        ATAI Life Sciences's portfolio, mapped.

        Stage
        Period
        9 of 9 deals

        See ATAI Life Sciences on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.